ID
31495
Description
Study ID: 104574 Clinical Study ID: AR1104574 Study Title: A randomized blinded pilot trial of fondaparinux sodium (Arixtra®) versus unfractionated heparin in addition to standard therapy in a broad range of patients undergoing percutaneous coronary intervention (ASPIRE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: fondaparinux sodium Trade Name: Arixtra Study Indication: Thromboembolism
Mots-clés
Versions (2)
- 28/08/2018 28/08/2018 -
- 28/08/2018 28/08/2018 -
Détendeur de droits
GlaxoSmithKline
Téléchargé le
28 août 2018
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Fondaparinux sodium (Arixtra) versus unfractionated heparin with patients undergoing PCI; Study ID: 104574
Blinded Anticoagulation Form
- StudyEvent: ODM
Description
Study Drug Accountability
Alias
- UMLS CUI-1
- C0013175
- UMLS CUI-2
- C0078889
Description
treatment allocation
Type de données
text
Alias
- UMLS CUI [1,1]
- C0087111
- UMLS CUI [1,2]
- C1706778
Description
allocated treatment given
Type de données
text
Alias
- UMLS CUI [1,1]
- C1706778
- UMLS CUI [1,2]
- C0580351
Description
actual treatment
Type de données
text
Alias
- UMLS CUI [1,1]
- C0087111
- UMLS CUI [1,2]
- C0237400
Description
ACT Measurement
Alias
- UMLS CUI-1
- C0427611
Description
ACT measurement during PCI
Type de données
text
Alias
- UMLS CUI [1,1]
- C0427611
- UMLS CUI [1,2]
- C0347984
- UMLS CUI [1,3]
- C1532338
Description
ACT measurement; research personnel informed
Type de données
text
Alias
- UMLS CUI [1,1]
- C0427611
- UMLS CUI [1,2]
- C0035173
- UMLS CUI [1,3]
- C1522154
Description
additional anticoagulant therapy during PCI
Type de données
text
Alias
- UMLS CUI [1,1]
- C0150457
- UMLS CUI [1,2]
- C1524062
- UMLS CUI [1,3]
- C0347984
- UMLS CUI [1,4]
- C1532338
Similar models
Blinded Anticoagulation Form
- StudyEvent: ODM
C2825181 (UMLS CUI [1,2])
C1300638 (UMLS CUI [1,3])
C2348585 (UMLS CUI [1,2])
C0078889 (UMLS CUI-2)
C1706778 (UMLS CUI [1,2])
C0580351 (UMLS CUI [1,2])
C0237400 (UMLS CUI [1,2])
C0347984 (UMLS CUI [1,2])
C1532338 (UMLS CUI [1,3])
C0035173 (UMLS CUI [1,2])
C1522154 (UMLS CUI [1,3])
C1524062 (UMLS CUI [1,2])
C0347984 (UMLS CUI [1,3])
C1532338 (UMLS CUI [1,4])